- Surgical Management of Hepatocellular Carcinoma
-
Lee KU, Lee HJ
- KMID: 863064
- Korean J Hepatol.
- 2002 Mar;8(1):1-21.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Which treatment modality should we choose for advanced hepatocellular carcinoma?
-
Kim DY
- KMID: 1117690
- Korean J Hepatol.
- 2010 Dec;16(4):353-354.
- doi: 10.3350/kjhep.2010.16.4.353
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A Clinical Analysis on Liver Transplantation for Hepatocellular Carcinomas
-
Park JH, Kim DG, Choi SH, Moon IS, Lee MD, Kim IC
- KMID: 772520
- Korean J Gastroenterol.
- 2003 Jul;42(1):42-49.
BACKGROUND/AIMS: Currently, the role of liver transplantation in the treatment of hepatocellular carcinoma (HCC) with cirrhosis is controversial. What remain to be determined are the best treatment protocol and... -
- CITED
-
- Close
- SHARE
-
- Close
- Predictive Factors of Palliative Radiotherapy Response and Survival in Patients with Spinal Metastases from Hepatocellular Carcinoma
-
Choi C, Seong J
- KMID: 2380788
- Gut Liver.
- 2015 Jan;9(1):94-102.
- doi: 10.5009/gnl14009
BACKGROUND/AIMS: Spinal metastases often severely limit the quality of life by causing severe pain and neurological deficits. The purpose of this study was to evaluate the palliative effect of radiotherapy... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Percutaneous Ethanol Injection Therapy in Korean with Hepatocellular Carcinoma
-
Kang HW, Kim YJ, Kim KM, Kang JM, Kim SH, Kim JH, Yoon WJ, Yoon JH, Yoon YB, Lee HS
- KMID: 1066041
- Korean J Gastroenterol.
- 2003 Dec;42(6):502-509.
BACKGROUND/AIMS: Percutaneous ethanol injection therapy (PEIT) is widely used for the treatment of hepatocellular carcinoma (HCC). However, its long-term therapeutic efficacy is not verified in Korea, one of hepatitis... -
- CITED
-
- Close
- SHARE
-
- Close
- Multivariate Analysis of the Predictors of Survival for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Focusing on Superselective Chemoembolization
-
Ji SK, Cho YK, Ahn YS, Kim MY, Park YO, Kim JK, Kim WT
- KMID: 1118875
- Korean J Radiol.
- 2008 Dec;9(6):534-540.
- doi: 10.3348/kjr.2008.9.6.534
OBJECTIVE: While the prognostic factors of survival for patients with hepatocellular carcinoma (HCC) who underwent transarterial chemoembolization (TACE) are well known, the clinical significance of performing selective TACE for HCC... -
- CITED
-
- Close
- SHARE
-
- Close
- Positron Emission Tomography with Fluorine-18-Fluorodeoxyglucose is Useful for Predicting the Prognosis of Patients with Hepatocellular Carcinoma
-
Kong YH, Han CJ, Lee SD, Sohn WS, Kim MJ, Ki SS, Kim J, Jeong SH, Kim YC, Lee JO, Cheon GJ, Choi CW, Lim SM
- KMID: 760564
- Korean J Hepatol.
- 2004 Dec;10(4):279-287.
BACKGROUND/AIMS: Hepatocellular carcinoma (HCC) is heterogenous in terms of its glucose metabolism. Positron emission tomography with fluorine-18-fluorodeoxyglucose (FDG-PET) shows various levels of FDG uptake for patients with HCC. This... -
- CITED
-
- Close
- SHARE
-
- Close
- Scheduled Interval Trans-Catheter Arterial Chemoembolization Followed by Radiation Therapy in Patients with Unresectable Hepatocellular Carcinoma
-
Yu JI, Park HC, Lim DH, Kim CJ, Oh D, Yoo BC, Paik SW, Kho KC, Lee JH
- KMID: 2157916
- J Korean Med Sci.
- 2012 Jul;27(7):736-743.
- doi: 10.3346/jkms.2012.27.7.736
Combination treatment of trans-catheter arterial chemoembolization (TACE) and conformal radiation therapy (RT) reported promising results in patients with hepatocellular carcinoma (HCC), but, optimal interval was not determined. We hypothesized that... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term outcome of preoperative transarterial chemoembolization and hepatic resection in patients with hepatocellular carcinoma
-
Kang JY, Choi MS, Kim SJ, Kil JS, Lee JH, Koh KC, Paik SW, Yoo BC
- KMID: 1117695
- Korean J Hepatol.
- 2010 Dec;16(4):383-388.
- doi: 10.3350/kjhep.2010.16.4.383
BACKGROUND/AIMS: Transarterial chemoembolization (TACE) improves the survival of patients with unresectable hepatocellular carcinoma (HCC) and has been recommended as a first-line therapy for nonsurgical patients with large or multifocal HCC.... -
- CITED
-
- Close
- SHARE
-
- Close
- Composite liver tumors: A radiologic-pathologic correlation
-
Nayyar M, Imagawa DK, Tirkes T, Demirjian , Houshyar R, Sandrasegaran K, Nangia CS, Seery T, Bhargava P, Choi JI, Lall C
- KMID: 2070261
- Clin Mol Hepatol.
- 2014 Dec;20(4):406-410.
- doi: 10.3350/cmh.2014.20.4.406
Bi-phenotypic neoplasm refers to tumors derived from a common cancer stem cell with unique capability to differentiate histologically into two distinct tumor types. Bi-phenotypic hepatocellular carcinoma-cholangiocarcinoma (HCC-CC), although a rare... -
- CITED
-
- Close
- SHARE
-
- Close
- Could patients who underwent hepatic resection due to hepatocellular carcinoma with high alpha-fetoprotein be monitored for recurrence by alpha-fetoprotein level?
-
Shin WY, Suh KS, Kim T, Jeon YM, Yi NJ, Lee KU
- KMID: 1792595
- Korean J Hepatol.
- 2010 Jun;16(2):168-175.
- doi: 10.3350/kjhep.2010.16.2.168
BACKGROUND/AIMS: The follow-up strategy after hepatectomy for hepatocellular carcinoma (HCC) usually depends on the experience of physician, resulting in frequent imaging studies, which leads to increased cost. Hence, we investigated... -
- CITED
-
- Close
- SHARE
-
- Close
- The Comparative Results of Radiofrequency Ablation versus Surgical Resection for the Treatment of Hepatocellular Carcinoma
-
Cho CM, Tak WY, Kweon YO, Kim SK, Choi YH, Hwang YJ, Kim YI
- KMID: 760581
- Korean J Hepatol.
- 2005 Mar;11(1):59-71.
BACKGROUND/AIMS: Although surgical resection remains the gold standard of therapy for hepatocellular carcinoma (HCC), only selected patients can undergo resection because of the severity of the underlying cirrhosis or... -
- CITED
-
- Close
- SHARE
-
- Close
- Surgical Treatment of Sclerosing Hepatocellular Carcinoma
-
Kim BS, Lee SG, Hwang S, Lee YJ, Park KM, Kim KH, Ahn CS, Moon DB, Ha TY, Song GW, Jung DH, Moon KM
- KMID: 760673
- Korean J Hepatol.
- 2006 Sep;12(3):412-419.
BACKGROUND/AIMS: Sclerosing hepatocellular carcinoma (HCC) is an unusual subtype of HCC that is characterized by an embedded dense fibrous stroma in the tubular neoplastic structures. We aimed to assess... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinicopathological Characteristics in Combined Hepatocellular-Cholangiocarcinoma: A Single Center Study in Korea
-
Park H, Choi KH, Choi SB, Choi JW, Kim DY, Ahn SH, Kim KS, Choi JS, Han KH, Chon CY, Park JY
- KMID: 1108067
- Yonsei Med J.
- 2011 Sep;52(5):753-760.
- doi: 10.3349/ymj.2011.52.5.753
PURPOSE: Combined hepatocellular-cholangiocarcinoma (CHCC) is an uncommon form of cancer, and its clinicopathological features have rarely been reported in detail. This study was undertaken to evaluate the clinicopathological characteristics and... -
- CITED
-
- Close
- SHARE
-
- Close
- Feasibility and Efficacy of Stereotactic Ablative Radiotherapy for Barcelona Clinic Liver Cancer-C Stage Hepatocellular Carcinoma
-
Bae SH, Kim MS, Cho CK, Kim KB, Lee DH, Han CJ, Park SC, Kim YH
- KMID: 1429183
- J Korean Med Sci.
- 2013 Feb;28(2):213-219.
- doi: 10.3346/jkms.2013.28.2.213
The purpose of this study was to assess the feasibility and efficacy of stereotactic ablative radiotherapy (SABR) for liver tumor in patients with Barcelona Clinic Liver Cancer (BCLC)-C stage hepatocellular... -
- CITED
-
- Close
- SHARE
-
- Close
- The retrospective cohort study for survival rate in patients with advanced hepatocellular carcinoma receiving radiotherapy or palliative care
-
Eun HS, Kim MJ, Kim HJ, Ko KH, Moon HS, Lee ES, Kim SH, Lee HY, Lee BS
- KMID: 1025198
- Korean J Hepatol.
- 2011 Sep;17(3):189-198.
- doi: 10.3350/kjhep.2011.17.3.189
BACKGROUND/AIMS: This study was conducted to investigate the assessment of treatment efficacy of radiotherapy (RT) and other therapeutic modalities compared with palliative care only for treatment with advanced hepatocellular carcinoma... -
- CITED
-
- Close
- SHARE
-
- Close
- Transcatheter Arterial Chemoembolization Plus ¹³¹I-Labelled Metuximab versus Transcatheter Arterial Chemoembolization Alone in Intermediate/Advanced Stage Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
-
Zhu ZX, Liao MH, Wang XX, Huang JW
- KMID: 2466285
- Korean J Radiol.
- 2016 Dec;17(6):882-892.
- doi: 10.3348/kjr.2016.17.6.882
OBJECTIVE: The aim of the study was to compare transcatheter arterial chemoembolization (TACE) plus ¹³¹I-labelled metuximab with TACE alone for hepatocellular carcinoma (HCC). MATERIALS AND METHODS: A comprehensive search was conducted... -
- CITED
-
- Close
- SHARE
-
- Close
- Transcatheter Arterial Chemoembolization for Infiltrative Hepatocellular Carcinoma: Clinical Safety and Efficacy and Factors Influencing Patient Survival
-
Han K, Kim JH, Yoon HM, Kim EJ, Gwon DI, Ko GY, Yoon HK, Ko HK
- KMID: 1731050
- Korean J Radiol.
- 2014 Aug;15(4):464-471.
- doi: 10.3348/kjr.2014.15.4.464
OBJECTIVE: To evaluate the safety and efficacy of transcatheter arterial chemoembolization (TACE) in patients with infiltrative hepatocellular carcinoma (HCC) and to identify the prognostic factors associated with patient survival. MATERIALS AND... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical significance and predictive factors of early massive recurrence after radiofrequency ablation in patients with a single small hepatocellular carcinoma
-
Cho JY, Choi MS, Lee GS, Sohn W, Ahn J, Sinn DH, Gwak GY, Paik YH, Lee JH, Koh KC, Paik SW
- KMID: 2373152
- Clin Mol Hepatol.
- 2016 Dec;22(4):477-486.
- doi: 10.3350/cmh.2016.0048
BACKGROUND/AIMS: Radiofrequency ablation (RFA) is one of the most frequently applied curative treatments in patients with a single small hepatocellular carcinoma (HCC). However, the clinical significance of and risk factors... -
- CITED
-
- Close
- SHARE
-
- Close
- Evaluation of the Heptocellular Carcinoma Staging Systems
-
Um SH
- KMID: 760654
- Korean J Hepatol.
- 2006 Jun;12(2):251-256.
Prospective validation of the Barcelona Clinic Liver Cancer staging system. Cillo U, Vitale A, Grigoletto F, Farinati F, Brolese A, Zanus G, Neri D, Boccagni P, Srsen N, D'Amico... -
- CITED
-
- Close
- SHARE
-
- Close
